(BIS)SULFONAMIDE DERIVATIVES

The present invention provides bissulphonamide derivatives of formula (I), in which R represents C1-6-alkyl, C2-6-alkenyl, or NR R ,R and R each independently represent hydrogen, C1-4.alkyl, F, aryl, or C1-6.alkylaryl; R and R each represent hydrogen; R represents C1-6-alkyl; n is an integer from 7...

Full description

Saved in:
Bibliographic Details
Main Authors KNOBELSDORF, JAMES, ALLEN, ZARRINMAYEH, HAMIDEH
Format Patent
LanguageEnglish
French
Published 23.05.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides bissulphonamide derivatives of formula (I), in which R represents C1-6-alkyl, C2-6-alkenyl, or NR R ,R and R each independently represent hydrogen, C1-4.alkyl, F, aryl, or C1-6.alkylaryl; R and R each represent hydrogen; R represents C1-6-alkyl; n is an integer from 7 to 14; and R and R each independently represent hydrogen or C1-4-alkyl; or a pharmaceutically acceptable salt thereof. Bissulphonamide derivatives of formula (I), in which R represents C1-6-alkyl, C2-6-alkenyl, or NR R , R , R , R , and R each represent hydrogen; R represents C1-6-alkyl; n is an integer from 6 to 14; and R and R each independently represent hydrogen or C1-4-alkyl; or a pharmaceutically acceptable salt thereof; are useful for potentiating glutamate receptor function in a mammal and, therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders. La présente invention concerne des dérivés de (bis)sulfonamide représentés par la formule (I) qui conviennent pour potentialiser la fonction du récepteur de glutamate chez un mammifère et qui convient, par conséquent, pour traiter une grande variété de pathologies, telles que des troubles psychiatriques et neurologiques.
Bibliography:Application Number: WO2001US10829